BioVox is a specialized life sciences news and communication platform keeping you up to date on the rapidly evolving life sciences sector in Belgium and on global scientific and industry trends. BioVox brings exclusive news, in-depth interviews, opinions, and insights on healthcare, agriculture and the bio-based economy. This information is shared with a national and international audience of life sciences professionals, at no cost to you!
We bring our news to you online, in a monthly newsletter (>20.000 life sciences subscribers), through white papers and via social media (Twitter and LinkedIn). Publications are short and easy to read. Our science editors and native English copywriters safeguard the quality and accuracy of our content.
Have a look at our event section to keep up-to-date with the latest conferences and presentations!
We help companies and research institutes gain international exposure and connect with the right target audiences
Looking to increase visibility? A tailor-made communication plan and dedicated content for your organization can be distributed both locally and internationally via our partnership with BioCentury. We have an extensive database of national and international journalists, reachable by custom-made press releases. Let us help you improve your communication and (inter)national reach! Simply contact us at firstname.lastname@example.org.
Ann Van Gysel (AVG) is CEO of Turnstone communications, the company behind BioVox, and represents KVCV section biotechnology. She studied Biology at the universities of Antwerp and Ghent and obtained a PhD in Molecular Genetics. She also holds a degree in Marketing and Communication and is specialized in biotech communications. Passionate about science communication, she established the VIB communications department and initated many of VIB's B2B and B2C communication activities. Ann became the Managing Director of FlandersBio in 2008. In 2011, she founded Turnstone Communications, a communications office specialized in life sciences. (LinkedIn)
Amy LeBlanc (ALB) graduated in 2017 with a MSc of Zoology from the University of Melbourne, in Australia. Her backround lies in ethology research and science communication; she has studied the song complexity of birds in addition to working as a science journalist. Having recently moved to Belgium, Amy is now focussing on a career in science communication, specializing in life sciences and biotech developments. She is currently a project manager at Turnstone Communications and Chief Editor at BioVox. (LinkedIn)
Jef Van der Borght (JVdB) graduated in 2006 as an MSc in Bioscience Engineering at Ghent University with a specialization in (industrial) biotechnology. He obtained a PhD in Bioscience Engineering from the same University in 2012 for his work on the engineering of disaccharide phosphorylases for the production of new disaccharides. Since, he moved his focus to the creation of online platforms and digital tools to improve consumer’s health. Jeff works for Turnstone Communications since 2015 as editor. (LinkedIn)
Dorien Staljanssens (DS) (LinkedIn)
Lenny Van Steenhuyse (LVS)
Emile Redant (ER) (LinkedIn)
Irina Lambertz (IL) (LinkedIn)
Gosia Kluba (GK) (LinkedIn)
Caroline Pallard (CP) (LinkedIn)
Amélie Moyaerts - Biowin (LinkedIn)
Henk Joos - FlandersBio (LinkedIn)
Frederik Wittock - Janssen Pharmaceutica (LinkedIn)
Jamila Louahed - GSK (LinkedIn)
Emile Pot - NLO (LinkedIn)
Paul Van Dun - KU Leuven (LinkedIn)
Esther Desmet - Ghent University (LinkedIn)
Christina Takke (LinkedIn) & Willem Broekaert (LinkedIn) - V-Bio Ventures
BioVox is an initiative from Turnstone Communications, KU Leuven, Ghent University, FlandersBio, BioWin, VIB, NLO, V-Bio Ventures, GSK and Janssen Pharmaceuticals.